Evidence map›Paper›PMID 41355379›Full record

SynthesisHealth technology assessment (Winchester, England)2025

Accuracy and clinical effectiveness of fetal growth monitoring strategies for the prediction of small for gestational age at birth: a systematic review and meta-analysis.

Evangelos Danopoulos, Nigel Armstrong, Kevin McDermott, Jiongyu Chen, Xiaoyu Tian, Caro Noake, Marie Westwood

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Health technology assessment (Winchester, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Evangelos DanopoulosKleijnen Systematic Reviews (KSR) Ltd, York, UK.ORCID 0000-0002-9186-8811
Nigel ArmstrongKleijnen Systematic Reviews (KSR) Ltd, York, UK.ORCID 0000-0002-7443-4798
Kevin McDermottKleijnen Systematic Reviews (KSR) Ltd, York, UK.ORCID 0000-0002-9415-8647
Jiongyu ChenKleijnen Systematic Reviews (KSR) Ltd, York, UK.ORCID 0009-0004-4518-1463
Xiaoyu TianKleijnen Systematic Reviews (KSR) Ltd, York, UK.ORCID 0009-0000-0993-2187
Caro NoakeKleijnen Systematic Reviews (KSR) Ltd, York, UK.ORCID 0000-0003-0329-4772
Marie WestwoodKleijnen Systematic Reviews (KSR) Ltd, York, UK.ORCID 0000-0002-6257-0653

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Smallness for gestational age has been associated with an increased risk of neonatal/fetal adverse outcomes. The Healthcare Safety Investigation Branch has issued a safety recommendation aimed at improving fetal growth monitoring strategies and reducing risk for babies. Objectives: The objective was to summarise available evidence to inform the Healthcare Safety Investigation Branch recommendation. The review comprised four research questions on: effects of fetal growth monitoring on neonatal/parental outcomes; effects of implementing fetal growth monitoring guidelines on neonatal/parental outcomes; accuracy of fetal growth monitoring strategies for predicting smallness for gestational age neonates/fetal growth restriction and factors affecting the accuracy of fetal growth monitoring strategies. Methods: Nineteen databases were searched from 2000 to March 2023 and were updated September 2023. Pregnant people with and without risk factors were included. Each review question had further eligibility criteria. For accuracy results, summary estimates of the sensitivity and specificity with 95% confidence intervals for the prediction of smallness for gestational age at delivery were calculated. Random-effects models were used for the meta-analysis of clinical outcomes. Further outcomes, including the results of risk of bias assessments, were summarised narratively. Results: Fifty-eight studies (78 publications) were included in the review. Q1 - Antenatal identification of smallness for gestational age pregnancies was associated with increased rates of intervention (two retrospective cohort studies, Limitations and conclusions: There is limited evidence linking fetal growth monitoring tests results to the changes in fetal/neonatal outcomes. There is some evidence supporting the reduction of adverse outcomes by Growth Assessment Protocol implementation. Testing during the third trimester is likely to result in more accurate prediction of smallness for gestational age at birth than earlier testing. Use of a locally derived reference chart for estimated fetal weight may result in optimised sensitivity for a given birthweight reference chart (definition of smallness for gestational age). Future work: Large diagnostic cohort studies and comparative studies are needed to further examine whether and how fetal growth monitoring testing and implementation of guidance can affect clinical outcomes. Study registration: This study is registered as PROSPERO CRD42023408030. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Evidence Synthesis programme (NIHR award ref: NIHR135862) and is published in full in

Indexed as

Fetal DevelopmentFetal Growth RetardationFetal MonitoringInfant, Small for Gestational AgeFemaleGestational AgeHumansInfant, NewbornPregnancyADVERSE NEONATAL OUTCOMESCAESAREAN BIRTHFETAL GROWTH MONITORINGFETAL GROWTH RESTRICTIONINDUCTION OF LABOURSMALL FOR GESTATIONAL AGESTILLBIRTHULTRASOUND

Identifiers

PMID41355379
PMCPMC12703561

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.